[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100579383":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":29,"responsibleParty":65,"collaborators":68,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":77,"acronym":10,"eligibilityCriteria":78,"healthyVolunteers":75,"sex":79,"minAge":80,"maxAge":10,"enrollmentInfo":81,"targetDuration":10,"studyType":84,"phases":10,"briefSummary":85,"conditions":86,"keywords":90,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Bryan Heart","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"VAD Clinician Cohort",null,"Up to four VAD Clinicians at each of the three participating sites (a maximum total of 12) will provide feedback and evaluation of the VAD AG Tool v5.0 following consenting.",{"label":13,"type":10,"description":14,"interventionNames":10},"VAD Patient Cohort","Each of the three sites will enroll a minimum of 3 patients and no more than 5 potential VAD patients (total of 21 for the three sites) to provide evaluation and feedback of accuracy and feasibility of the VAD AG Tool v5.0, occurring at 3-, 6- and 12-months following VAD implant. All patient participants following consenting, will receive the tool pre-surgery and provide evaluation and guidance post surgery, along with de-identifiable demographic and clinic data.",[16],{"name":17,"affiliation":5,"role":18},"Mathue Baker, MD","STUDY_CHAIR",[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Sarah E Schroeder, PhD, MSN, BSN, RN-Diploma","CONTACT","402-481-8450","sarah.schroeder@bryanheart.com",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Kristin Sandau, PhD, RN","612-625-0186","KSandau@umn.edu",[30,47],{"facility":5,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Lincoln","Nebraska","68506","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-96.66696,40.8,{"lat":41,"lon":40},[44],{"name":45,"role":22,"phone":46,"phoneExt":10,"email":24},"Sarah E Schroeder, PhD, MSN, BSN, RN","4024833333",{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":35,"countryCode":36,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Advocate Aurora Health","NOT_YET_RECRUITING","Milwaukee","Wisconsin","53215",{"type":38,"coordinates":54},[55,56],-87.90647,43.0389,{"lat":56,"lon":55},[59,63],{"name":60,"role":22,"phone":61,"phoneExt":10,"email":62},"Riley Rossbach, BSBME","4142227434","riley.rossbach@aah.org",{"name":60,"role":64,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":64,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Sarah E Schroeder","Left Ventricular Assist Device Nurse Practitioner and Program Manager",[69,71],{"name":70,"class":6},"International Consortium of Circulatory Assist Clinicians",{"name":72,"class":6},"International Society for Heart and Lung Transplantation","100579383","multi-site-feasibility-testing-of-the-ventricular-assist-device-anticipatory-guidance-tool-100579383",false,"NCT06823583","Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool","Inclusion Criteria:\n\n(For patient inclusion):\n\n* scheduled for a VAD implantation\n* English-speaking as the VAD AG Tool v5.0 has not yet been translated beyond English age ≥19 years at the time of implant as most states in North America have an age of majority for consent signing.\n\n(-VAD clinician for the clinician evaluation process)\n\nExclusion Criteria:\n\n* Not scheduled for VAD surgery\n* Non English speaking\n* \\\u003C19 yrs of age (Not a VAD Clinician for the clinician evaluation process)","ALL","19 Years",{"count":82,"type":83},10,"ESTIMATED","OBSERVATIONAL","There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to potential participants to help understand areas of satisfaction and concern following a VAD implant as various time points. The investigators want to provide better patient care through increased education and awareness beyond surgical outcomes and contribute to patient understanding of \"what to expect\" following a VAD implant.\n\nThe investigators have created an anticipatory guidance (AG) tool based upon previous responses recorded in a local program's database, from the Quality of Life with a Left Ventricular Assist Device (QoLVAD) questionnaire. This questionnaire has five different domains (physical, social, emotional, cognitive thinking and spiritual\u002Fwell-being). Investigators have previously analyzed responses to determine common areas of satisfaction and concern at 3-, 6-, 12- and 24-months post-VAD implant to better understand quality of life when living with a VAD. Investigators have had both VAD clinicians and VAD patients initially evaluate the tool to determine accuracy and effectiveness of the anticipatory guidance (AG) tool.",[87,88,89],"Ventricular Assist Device","Advanced Heart Failure","Anticipatory Guidance",[91,92,88,89,93],"expectations","VAD","quality of life","2025-09-15",{"date":96,"type":97},"2025-09-19","ACTUAL",{"date":99,"type":97},"2025-08-17",{"date":101,"type":83},"2026-12",{"name":5,"class":6},2]